Product
CBT102-A
1 clinical trial
1 indication
Indication
PhenylketonuriaClinical trial
Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria：a Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical StudyStatus: Recruiting, Estimated PCD: 2023-12-01